Key points are not available for this paper at this time.
Design
Review
Giant cell myocarditis is a rare, fulminant disease with a poor prognosis that presents significant clinical challenges.
G iant cell myocarditis (GCM) remains a feared diagnosis among health care providers.This disease has remained somewhat of an enigma over the years, partly because of its low incidence, often fulminant clinical presentation with similarities to other forms of myocarditis (both clinically and histopathologically), variable treatment approaches, frequently rapid clinical progression, and overall poor prognosis.GCM presents significant challenges at all stages of its disease course, from its
No takes yet. Share an insight, caveat, or question.
Nowell M. Fine (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: